Toxoplasma gondii, an intracellular coccidian protozoan parasite.
Ingestion of soil, water, or food contaminated with cat feces, ingestion of undercooked meat or shellfish, congenital transmission from a woman infected during or shortly before pregnancy, and contaminated blood transfusion and organ transplantation.
T. gondii is endemic throughout most of the world. Risk is higher in developing and tropical countries, especially when people eat undercooked meat or shellfish, drink untreated water, or have extensive soil exposure. Congenital transmission can also occur if a woman is infected during pregnancy.
Incubation period is 5–23 days. Symptoms may include influenzalike symptoms or a mononucleosis syndrome with prolonged fever, lymphadenopathy, elevated liver enzymes, lymphocytosis, and weakness. Rarely, chorioretinitis or disseminated disease can occur in immunocompetent people. In severely immunocompromised people, severe and even fatal encephalitis, pneumonitis, and other systemic illnesses can occur, most often from reactivation of a previous infection. Infants with congenital toxoplasmosis are often asymptomatic, but eye disease, neurologic disease, or other systemic symptoms can occur, and learning disabilities, cognitive deficits, or visual impairments may develop later in life.
Serologic tests for T. gondii antibodies are available at commercial diagnostic laboratories; however, because of the inherent difficulty in diagnosing acute toxoplasmosis, physicians are advised to seek confirmatory testing through the reference laboratory at Sutter Health Palo Alto Medical Foundation Toxoplasma Serology Laboratory (www.pamf.org/serology). Eye disease is diagnosed by ocular examination. Diagnosis of toxoplasmic encephalitis in immunocompromised people (most often seen in people with AIDS) can be based on typical clinical course and identification of ≥1 mass lesion by CT or MRI. Biopsy may be needed to make a definitive diagnosis.
Treatment is reserved for acutely infected pregnant women and those with severe disease or who are immunocompromised. A number of regimens are available, but the recommended regimen includes pyrimethamine, sulfadiazine, and leucovorin (folinic acid). Alternative treatment regimens include clindamycin, atovaquone, and azithromycin, but these have not been extensively studied. The recommended treatment regimen for acutely infected pregnant women depends on the timing of infection during gestation; physicians are advised to seek consultation with a specialist before initiating therapy in these patients.
Food and water precautions (see Chapter 2, Food & Water Precautions). Avoid direct contact with soil or sand that may be contaminated with cat feces. If caring for a cat, change the litter box daily. If pregnant or immunocompromised, avoid changing cat litter, if possible, and do not adopt or handle stray cats. Wash hands with soap and water after gardening, contact with soil or sand, and after changing cat litter.
Anand R, Jones CW, Ricks JH, Sofarelli TA, Hale DC. Acute primary toxoplasmosis in travelers returning from endemic countries. J Travel Med. 2012 Jan–Feb;19(1):57–60.
Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004 Jun 12;363(9425):1965–76.
Maldonado YA, Read JS, AAP Committee on Infectious Diseases. Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States. Pediatrics. 2017;139(2):e20163860.
Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. [updated Nov 29 2018; cited 2019 Jan 10]. Available from: https://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf.
Sepulveda-Arias JC, Gomez-Marin JE, Bobic B, Naranjo-Galvis CA, Djurkovic-Djakovic O. Toxoplasmosis as a travel risk. Travel Med Infect Dis. 2014 Nov–Dec;12(6 Pt A):592–601.
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.